Magellan Health Form 3 / Mostafa Kamal ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kamal Mostafa

(Last)

(First)

(Middle)

15950 NORTH 76TH STREET

SUITE 200

(Street)

SCOTTSDALE

85260

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2015

3. Issuer Name and Ticker or Trading Symbol
MAGELLAN HEALTH INC [ MGLN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
CEO, Magellan Rx Management

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)	⁽¹⁾	04/01/2025	Common Stock	5,000	71	D
Stock Option (right to buy)	⁽¹⁾	03/04/2025	Common Stock	4,441	63.95	D
Stock Option (right to buy)	⁽²⁾	03/05/2023	Common Stock	157	53	D
Restricted Stock Units	⁽³⁾	⁽⁴⁾	Common Stock	525	⁽⁴⁾	D
Performance Stock Units - 3/4/15	⁽⁵⁾	⁽⁴⁾	Common Stock	395	⁽⁴⁾	D
Performance Stock Units (EPS) 3/5/14	⁽⁶⁾	⁽⁴⁾	Common Stock	29	⁽⁴⁾	D
Performance Stock Units (ROE) 3/5/14	⁽⁶⁾	⁽⁴⁾	Common Stock	29	⁽⁴⁾	D
Performance Stock Units (EPS) 3/5/14	⁽⁶⁾	⁽⁴⁾	Common Stock	29	⁽⁴⁾	D
Performance Stock Units (ROE) 3/5/14	⁽⁶⁾	⁽⁴⁾	Common Stock	28	⁽⁴⁾	D
Performance Stock Units (C) 3/5/13	⁽⁶⁾	⁽⁴⁾	Common Stock	29	⁽⁴⁾	D

Explanation of Responses:

1. Options shall vest and become exercisable in one-third increments on March 4 of each of 2016, 2017 and 2018.

2. of the 472 options granted, 315 have previously vested and exercised. The remainder of 157 options shall vest on March 5, 2016.

3. Restricted Stock Units shall vest in one third increments on March 5 of each of 2016, 2017 and 2018.

4. Not applicable.

5. Performance Stock Units shall vest on March 4, 2018.

6. Performance Stock Units shall vest on March 5, 2016 subject to performance restrictions.

Remarks:

	/s/ Mostafa Kamal	07/10/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Magellan Health (MGLN) Form 3MAGELLAN HEALTH / Mostafa Kamal ownership change